UroGen Pharma Ltd: Weathering Stock Market Storms with 783.57M Market Cap

The stock price for UroGen Pharma Ltd (URGN) currently stands at $16.96. The stock experienced a substantial increase in the last session, hitting $50.0 after starting at $16.96. The stock’s lowest price was $16.0 before closing at $15.46.

UroGen Pharma Ltd saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $17.00 on 07/22/25, while the lowest price for the same duration was marked at $3.42 on 05/21/25.

52-week price history of URGN Stock

A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. UroGen Pharma Ltd’s current trading price is -0.24% away from its 52-week high, while its distance from the 52-week low is 395.91%. The stock’s price range during this period has spanned from $3.42 to $17.00. In the Healthcare sector, the UroGen Pharma Ltd’s shares surpassed a trading volume of approximately 2.11 million for the day, which was noticeably lower compared to the average daily volume of 9.3.05 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

UroGen Pharma Ltd (URGN) has experienced a quarterly rise of 75.57% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 783.57M and boasts a workforce of 235 employees.

A Closer Look at Analysts’ Ratings for UroGen Pharma Ltd

As of right now, 5 analysts are rating UroGen Pharma Ltd as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.59, with a change in price of +7.60. Similarly, UroGen Pharma Ltd recorded 2,083,081 in trading volume during the last 100 days, posting a change of +81.20%.

URGN Stock Stochastic Average

Today’s raw stochastic average for UroGen Pharma Ltd over the last 50 days is 97.69%.This indicates a increase from the raw stochastic average of the past 20 days, which was 92.97%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 88.21% and 84.56%, respectively.

URGN Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price increase of 1.92%. However, over the past six months, we’ve seen a weaker performance of 65.14%. The price of URGN fallen by 15.77% over the last 30 days. And in the last five days, it has surged by 20.80%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.